Table 1 Demographic, pathological features and surgical interventions
n | % | |
|---|---|---|
Age (year) | ||
Median (min–max) | 49 (26–68) | |
Mean ± SD | 50.27 ± 10.83 | |
≤ 50 | 18 | 56.3 |
> 50 | 14 | 43.7 |
Menopausal status | ||
Premenopausal | 17 | 53.2 |
Postmenopausal | 15 | 46.8 |
Surgical interventions | ||
Simple mastectomy | 5 | 15.6 |
Areola sparing mastectomy | 12 | 37.5 |
Skin sparing mastectomy | 1 | 3.1 |
Breast conserving surgery | 14 | 43.8 |
Axillary approach | ||
SLNB (−) | 24 | 75 |
SLNB (+) | 5 | 15.7 |
ALND | 3 | 9.3 |
HER-2 | ||
Negative | 21 | 65.7 |
Positive | 11 | 34.3 |
ER | ||
Negative | 7 | 21.8 |
Positive | 25 | 78.2 |
PR | ||
Negative | 12 | 37.5 |
Positive | 20 | 62.5 |
Ki-67 (%) | ||
Median (Min–Max) | 32.5 (12–90) | |
Mean ± SD | 38.9 ± 18.8 | |
Ki-67 ≤ 20 | 5 | 15.6 |
Ki-67 > 20 | 27 | 84.4 |
Histological grade | ||
Grade 2 | 10 | 31.2 |
Grade 3 | 22 | 68.8 |
High TIL density (>10%) | ||
Negative | 20 | 62.5 |
Positive | 12 | 37.5 |
Receptor status | ||
Luminal B | 26 | 81.2 |
HER2 positive | 3 | 9.4 |
Triple negative | 3 | 9.4 |
Luminal | ||
Negative | 6 | 18.7 |
Positive | 26 | 81.3 |
T stage | ||
T1 | 9 | 28.1 |
T2 | 23 | 71.9 |
N stage | ||
N0 | 23 | 71.9 |
N1 | 9 | 28.1 |
Stage | ||
Stage 1 | 9 | 28.1 |
Stage 2 | 23 | 71.9 |
Lymphovascular invasion | ||
Negative | 16 | 50 |
Positive | 16 | 50 |
Extensive intraductal component | ||
Negative (< 20%) | 21 | 65.7 |
Positive (> 20%) | 11 | 34.3 |